Background: Peripartum cardiomyopathy (PPCM) mortality rates vary between 2% and 56%, with half occurring ≤12 weeks'; postpartum. Although risk factors for PPCM have been identified, predicting sudden cardiac death among PPCM patients remains difficult. This study describes the characteristics and outcomes of PPCM patients and controls referred for a wearable cardioverter defibrillator (WCD).
Methods And Results: Deidentified WCD medical orders between 2003 and 2009 and death index searches were used to characterize women (ages 17-43) with PPCM (n = 107) or matched nonpregnant women with nonischemic dilated cardiomyopathy (NIDCM; n = 159). Demographics were similar. WCD use averaged 124 ± 123 days and 96 ± 83 days among PPCM and NIDCM patients, respectively. No PPCM patients received an appropriate shock for ventricular tachycardia/ventricular fibrillation; 1 NIDCM patient received 2 successful shocks. No PPCM patient died during WCD use versus 11 concurrent NIDCM deaths. After WCD use, 3 PPCM and 13 NIDCM patients died, respectively.
Conclusions: The mortality rate of 2.8% (over 3.0 ± 1.2 years) in PPCM patients is low compared to published data. The role of WCD therapy among PPCM patients deserves further study.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.cardfail.2011.09.004 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Diagnosis and management of peripartum cardiomyopathy and recurrence risk.
Int J Cardiol Congenit Heart Dis
September 2024
Adult Congenital Heart Diseases Unit, Royal Brompton Hospital, London, UK.
Peripartum cardiomyopathy (PPCM) is a rare, but serious condition, with a non-negligible risk of adverse events. Several risk factors for PPCM have been individuated over the years, including Afro-American ethnicity, preeclampsia, advanced maternal age, genetic predisposition, multiparity, twin pregnancy, obesity, smoking and diabetes. However, PPCM pathophysiology is still poorly understood, thus making it challenging to develop disease specific therapies.
View Article and Find Full Text PDFThe triglyceride-to-high-density lipoprotein cholesterol ratio is associated with an increased risk of peripartum cardiomyopathy.
Front Endocrinol (Lausanne)
December 2024
The Key Laboratory of Cardiovascular Remodeling and Function Research, The State and Shandong Province Joint Key Laboratory of Translational Cardiovascular Medicine, Department of Cardiology, Cheeloo College of Medicine, Qilu Hospital, Chinese Ministry of Education, Chinese National Health Commission and Chinese Academy of Medical Sciences, Shandong University, Jinan, China.
Article Synopsis
- Peripartum cardiomyopathy (PPCM) is a severe heart failure condition affecting women during late pregnancy and after childbirth, with its diagnosis being complex and influenced by various factors, including abnormal lipid metabolism.
- A study involving 600 parturients found that the triglyceride to high-density lipoprotein cholesterol (TG/HDL-C) ratio was significantly higher in those with PPCM compared to healthy subjects, indicating a potential risk factor.
- The analysis showed that a higher TG/HDL-C ratio not only increased the risk of developing PPCM but also proved to be a reliable predictor for its onset, suggesting its importance in monitoring pregnant women.
Gene Analysis of Four Families with Severe Peripartum Cardiomyopathy Reveals Known Gene Mutations and Supports the Recent Call for Screening.
Rev Cardiovasc Med
November 2024
Department of Obstetrics & Gynecology, National Clinical Research Center for Obstetric & Gynecologic Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, 100730 Beijing, China.
Article Synopsis
- Peripartum cardiomyopathy (PPCM) is a serious condition affecting mothers that has unclear causes and varying recovery rates; genetic research may help understand it better.* -
- A study screened six patients with severe PPCM and their families, finding that 66% had pathogenic genetic mutations, with a high rate of mutation shared among family members.* -
- The research suggests that for women genetically predisposed to PPCM, pregnancy might worsen their condition, highlighting the importance of genetic counseling for those with family histories of heart disease.*
Myocardial Posttranscriptional Landscape in Peripartum Cardiomyopathy.
Circ Heart Fail
December 2024
School of Medical Sciences, Faculty of Medicine and Health, University of Sydney, NSW, Australia (A.L., B.F., Y.C.K., C.M., B.H., D.H., C.G.d.R., M. Larance, J.F.O., S.L.).
Article Synopsis
- Pregnancy causes significant changes in a woman’s heart and vascular system, but some women can develop a heart condition called peripartum cardiomyopathy (PPCM) during or after pregnancy which can lead to heart failure.
- A study used mass spectrometry to compare protein and metabolite profiles from heart tissue of patients with end-stage PPCM against those with dilated cardiomyopathy (DCM) and non-failing heart donors, aiming to understand the molecular differences.
- Findings revealed two specific proteins (SBSPON and TNS3) were downregulated in PPCM, disrupting tissue remodeling, while certain metabolites showed abnormal levels indicating altered metabolic functions; both PPCM and DCM shared some inflammatory pathways but differed significantly in thyroid
Subsequent pregnancies in peripartum cardiomyopathy: Patient-level differences and decision-making.
Am Heart J Plus
November 2024
Pregnancy and Perinatal Research Center, Department of Obstetrics and Gynecology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, United States of America.
Study Objective: To evaluate patient-level differences and decision making surrounding subsequent pregnancies (SSP) after peripartum cardiomyopathy (PPCM).
Design: Mixed methods approach to evaluate quantitative demographic and clinical differences between patients with and without a SSP and to qualitatively describe the decision-making regarding a SSP with a survey component.
Setting/participants: 220 PPCM cases within the University of Pennsylvania Health System.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!